scholarly article | Q13442814 |
P356 | DOI | 10.1021/JM00329A013 |
P953 | full work available at URL | https://pubs.acs.org/doi/pdf/10.1021/jm00329a013 |
P698 | PubMed publication ID | 5867942 |
P2093 | author name string | P. S. Portoghese | |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | molecular medicine | Q3523816 |
P304 | page(s) | 609-616 | |
P577 | publication date | 1965-09-01 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | A new concept on the mode of interaction of narcotic analgesics with receptors | |
A New Concept on the Mode of Interaction of Narcotic Analgesics with Receptors | |||
P478 | volume | 8 |
Q52885622 | 1 Stereochemical Aspects of Parasympathomimetics and their Antagonists: Recent Developments |
Q43968670 | A model system for opiate-receptor interactions: Mechanism of opiate-cerebroside sulfate interaction |
Q44330858 | A novel opioid structure which accepts protonated as well as non-protonated nitrogen: A family of pure, delta receptor selective antagonists |
Q44352546 | Affinities of some common opioid analgesics towards four binding sites in mouse brain |
Q34246097 | Analgesic and other pharmacological activities of a new narcotic antagonist analgesic (-)-1-(3-methyl-2-butenyl)-4-[2-(3-hydroxyphenyl)-1-phenylethyl]piperazine and its enantiomorph in experimental animals |
Q39775210 | Analgesics and their antagonists: recent developments |
Q72842203 | Antibodies to Cerebroside Sulfate Inhibit the Effects of Morphine and β-Endorphin |
Q34560835 | Conformation-activity relationships of opiate analgesics |
Q47783481 | Conformational sampling of bioactive conformers: a low-temperature NMR study of 15N-Leu-enkephalin |
Q34773986 | Drug dependence: neuropharmacology and management. |
Q92651109 | Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand Design |
Q26860519 | Dynorphin--still an extraordinarily potent opioid peptide |
Q34986433 | Endogenous opioid peptides: multiple agonists and receptors |
Q44352094 | Evidence for a single opioid receptor type on the field stimulated rat vas deferens |
Q22242288 | Functional Selectivity and Classical Concepts of Quantitative Pharmacology |
Q24649793 | Herkinorin analogues with differential beta-arrestin-2 interactions |
Q36633126 | Imaging of opioid receptors in the central nervous system |
Q37982557 | Influence of opioids on central thermoregulatory mechanisms |
Q38312641 | Kappa Opioid Receptor Agonist and Brain Ischemia |
Q44333408 | Kappa opioid receptors are expressed by interneurons in the CA1 area of the rat hippocampus: a correlated light and electron microscopic immunocytochemical study |
Q57951990 | Low temperature nmr studies of leu-enkephalins in cryoprotective solvents |
Q42163816 | Molecular-dynamics simulations of [Met5]- and [D-Ala2,Met5]-enkephalins. Biological implication of monomeric folded and dimeric unfolded conformations |
Q33581970 | Mu opioid receptors in pain management |
Q37236111 | Mu opioids and their receptors: evolution of a concept |
Q41735966 | Naloxone resistant changes in body temperature of the cat induced by intracerebroventricular injection of pentazocine |
Q66960662 | Opiate binding to cerebroside sulfate: A model system for opiate-receptor interaction |
Q34729984 | Opioid receptor desensitization: mechanisms and its link to tolerance |
Q39218021 | Opioids and behavior: genetic aspects |
Q34437456 | Opioids and their receptors: Are we there yet? |
Q39590918 | Peptides of the Central Nervous System |
Q66960666 | Plasma cholinesterase and the morphine receptor |
Q35062599 | Proposal for the biologically active conformation of opiates and enkephalin |
Q24631212 | Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonists |
Q67318943 | Stereochemical Considerations in Structural Comparison of Enkephalins and Endorphins with Exogenous Opiate Agents |
Q47846187 | Stereospecific binding of narcotics to brain cerebrosides |
Q48392018 | Structural and conformational relationships between the enkephalins and the opiates |
Q57159474 | Structure-Activity Relationship Studies of 6α- and 6β-Indolylacetamidonaltrexamine Derivatives as Bitopic Mu Opioid Receptor Modulators and Elaboration of the "Message-Address Concept" To Comprehend Their Functional Conversion |
Q53001437 | Structure-activity relationships of normeperidine congeners on cholinesterase systems in vitro and analgesia in vivo |
Q72381500 | Substituted tetralins I: Synthesis and Analgesic Activities of Some 2-Aminotetralins |
Q36439007 | Supraspinal peroxynitrite modulates pain signaling by suppressing the endogenous opioid pathway |
Q37349472 | Synthesis and pharmacological evaluation of hydrophobic esters and ethers of butorphanol at opioid receptors |
Q38007903 | The action of opioid drugs on human plasma cholinesterase |
Q34578586 | The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system |
Q39448354 | The efficacy of delta-opioid receptor-selective drugs |
Q39151855 | The enkephalins and opiates: structure-activity relations |
Q46222547 | The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone |
Q40210197 | The natural tolerance of the afghan pika (Ochotona rufescens) to morphine |
Q39338563 | The next frontier in the molecular biology of the opioid system. The opioid receptors |
Q39175820 | The opiate anomalies — another possible explanation? |
Q41815605 | X-ray diffraction studies of enkephalins. Crystal structure of [(4'-bromo) Phe4,Leu5]enkephalin |
Search more.